Errata (DOI:10.1016/j.survophthal.2007.12.006);The Role of Calcium-Activated Protease Calpain in Experimental Retinal Pathology

Survey of Ophthalmology

Volumn 53, Issue 2, 2008, Pages 150-163

  Azuma, M ^a   Shearer, T R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

calpain; calpain activation; calpain inhibitors; glaucoma models; human disease; molecular genetics; molecular modeling; neurochemistry; neuropathology; retina; retinitis pigmentosa models; x ray diffraction

Indexed keywords

CALPAIN; CALPAIN 1; CALPAIN 2; CALPAIN 3; CALPASTATIN; CATHEPSIN B; CATHEPSIN L; N (4 FLUOROPHENYLSULFONYL)VALYLLEUCINAL; SJA 6017; SNJ 1945; UNCLASSIFIED DRUG; [[[1 (1 BENZYL 3 CYCLOPROPYLAMINO 2,3 DIOXOPROPYL)AMINO]CARBONYL] 3 METHYLBUTYL]CARBAMIC ACID 5 METHOXY 3 OXAPENTYL ESTER;

AGING; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; AUTOLYSIS; CALCIUM CELL LEVEL; CELL DEATH; DRUG SAFETY; GENE DELETION; GLAUCOMA; HUMAN; HYPOXIA; IMMUNOBLOTTING; INTRAOCULAR PRESSURE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETINA DISEASE; RETINITIS PIGMENTOSA; X RAY DIFFRACTION; ZYMOGRAPHY;

EID: 40749157087     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2008.05.001     Document Type: Erratum

References (64)

1. Arrington D.D., Van Vleet T.R., and Schnellmann R.G. Calpain 10-a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction. Am J Physiol Cell Physiol 291 (2006) C1159-C1171
2. Artal-Sanz M., and Tavernarakis N. Proteolytic mechanisms in necrotic cell death and neurodegeneration. FEBS Lett 579 (2005) 287-296
3. Azarian S.M., King A.J., Hallett M.A., et al. Selective proteolysis of arrestin by calpain. Molecular characteristics and its effect on rhodopsin dephosphorylation. J Biol Chem 270 (1995) 24375-24384
4. Azarian S.M., Schlamp C.L., and Williams D.S. Characterization of calpain II in the retina and photoreceptor outer segments. J Cell Sci 105 (1993) 787-798
5. Azarian S.M., and Williams D.S. Calpain activity in the retinas of normal and RCS rats. Curr Eye Res 14 (1995) 731-735
6. Azuma M., Fukiage C., David L.L., et al. Activation of calpain in lens: a review and proposed mechanism. Exp Eye Res 64 (1997) 529-538
7. Azuma M., Fukiage C., Higashine M., et al. Identification and characterization of a retina-specific calpain (Rt88) from rat. Curr Eye Res 21 (2000) 710-720
8. Azuma M., Sakamoto-Mizutani K., Nakajima T., et al. Involvement of calpain isoforms in retinal degeneration in WBN/Kob rats. Comp Med 54 (2004) 533-542
9. Bartus R.T., Dean R.L., Mennerick S., et al. Temporal ordering of pathogenic events following transient global ischemia. Brain Res 790 (1998) 1-13
10. Chang B., Hawes N.L., Hurd R.E., et al. Retinal degeneration mutants in the mouse. Vis Res 42 (2002) 517-525
11. Chiu K., Lam T.T., Ying Li W.W., et al. Calpain and N-methyl-d-aspartate (NMDA)-induced excitotoxicity in rat retinas. Brain Res 1046 (2005) 207-215
12. Chung C.W., Song Y.H., Kim I.K., et al. Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol Dis 8 (2001) 162-172
13. Cuerrier D., Moldoveanu T., Inoue J., et al. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography. Biochem 45 (2006) 7446-7452
14. Das A., Garner D.P., Del Re A.M., et al. Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res 1084 (2006) 146-157
15. Donkor I.O. A survey of calpain inhibitors. Curr Med Chem 7 (2000) 1171-1188
16. Doonan F., Donovan M., and Cotter T.G. Activation of multiple pathways during photoreceptor apoptosis in the rd mouse. Invest Ophthalmol Vis Sci 46 (2005) 3530-3538
17. Ethen C.M., Reilly C., Feng X., et al. The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 47 (2006) 2280-2290
18. Forrester J.V., Dick A.D., MeMenamin P.G., et al. Anatomy of the eye and orbit. The Eye, Basic Sciences in Practice. ed 2 (2002), W B Saunders, New York, NY 37
19. Fukiage C., Azuma M., Nakamura Y., et al. SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses. Biochim Biophys Acta 1361 (1997) 304-312
20. Fukuda S., Harada K., Kunimatsu M., et al. Postischemic reperfusion induces alpha-fodrin proteolysis by m-calpain in the synaptosome and nucleus in rat brain. Neurochem 70 (1998) 2526-2532
21. Goll D.E., Thompson V.F., Li H., et al. The calpain system. Physiol Rev 83 (2003) 731-801
22. Inomata H., Uyoma M., Okisaka S., et al. Glaucomatous damage of retina and optic nerve. Ocular Cell Biology (2000), Nakayama-Shoten Co., Ltd., Tokyo Fig 4, p. 139 (Jap)
23. Inoue J., Nakamura M., Cui Y.S., et al. Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor. J Med Chem 46 (2003) 868-871
24. Khorchid A., and Ikura M. How is calpain activated by calcium. Nat Struct Biol 9 (2002) 239-241
25. Kupina N.C., Nath R., Bernath E.E., et al. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J Neurotrauma 18 (2001) 1229-1240
26. Kusakawa G., Saito T., Onuki R., et al. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. Biol Chem 275 (2000) 17166-17172
27. Ma H., Shih M., Hata I., et al. Protein for Lp82 calpain is expressed and enzymatically active in young rat lens. Exp Eye Res 67 (1998) 221-229
28. Moldoveanu T., Campbell R.L., Cuerrier D., et al. Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site. J Mol Biol 343 (2004) 1313-1326
29. Nakajima E., David L.L., Bystrom C., et al. Calpain-specific proteolysis in primate retina: contribution of calpains in cell death. Invest Opthalmol Vis Sci 47 (2006) 5469-5475
30. Nakajima E., Walkup R.D., Ma H., et al. Low activity by the calpain system in primate lenses causes resistance to calcium-induced proteolysis. Exp Eye Res 83 (2006) 593-601
31. Nakajima T., Fukiage C., Azuma M., et al. Different expression patterns for ubiquitous calpains and Capn3 splice variants in monkey ocular tissues. Biochim Biophys Acta 1519 (2001) 55-64
32. Nath R., Davis M., Probert A.W., et al. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem Biophys Res Commun 274 (2000) 16-21
33. Nath R., Raser K.J., Stafford D., et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J 319 (1996) 683-690
34. Nixon R.A. Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neurons. J Neurosci 6 (1986) 1264-1271
35. Nixon R.A., Saito K.I., Grynspan F., et al. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 747 (1994) 77-91
36. Oka T., Nakajima T., Tamada Y., et al. Contribution of calpains to photoreceptor cell death in N-methyl-N-nitrosourea treated rats. Exp Neurol 204 (2007) 39-48
37. Oka T., Tamada Y., Nakajima E., et al. Presence of calpain-induced proteolysis in retinal degeneration and dysfunction in rat acute hypertension model. J Neurosci Res 83 (2006) 1342-1351
38. Oka T., Walkup R.D., Tamada Y., et al. Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1s)-1-((((1s)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl) amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester. J Neurosci 141 (2006) 2139-2145
39. Ono Y., Shimada H., Sorimachi H., et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 273 (1998) 17073-17078
40. Pang J., Cheng M., Haire S.E., et al. Efficiency of lentiviral transduction during development in normal and rd mice. Mol Vis 12 (2006) 756-767
41. Paquet-Durand F., Azadi S., Hauck S.M., et al. Calpain is activated in degenerating photoreceptors in the rd1 mouse. J Neurochem 96 (2006) 802-814
42. Persson H., Kawashima S., and Karlsson J.O. Immunohistochemical localization of calpains and calpastatin in the rabbit eye. Brain Res 611 (1993) 272-278
43. Quiniou C., Sennlaub F., Beauchamp M.H., et al. Dominant role for calpain in thromboxane-induced neuromicrovascular endothelial cytotoxicity. J Pharmacol Exp Ther 316 (2006) 618-627
44. Robertson L.J., Morton J.D., Yamaguchi M., et al. Calpain may contribute to hereditary cataract formation in sheep. Invest Ophthalmol Vis Sci 46 (2005) 4634-4640
45. Saatman K.E., Bozyczko-Coyne D., and Marcy V. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol 55 (1996) 850-860
46. Saido T.C., Yokota M., Nagao S., et al. Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem 268 (1993) 25239-25243
47. Sakamoto Y.R., Nakajima T.R., Fukiage C.R., et al. Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina. Curr Eye Res 21 (2000) 571-580
48. Sanvicens N., and Cotter T.G. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J Neurochem 98 (2006) 1432-1444
49. Sasaki M., Kunimatsu M., Ozaki Y., et al. Medical Aspects of Proteases and Protease Inhibitors (1997), IOS Press, Burke, VA pp. 43-57
50. Schoenwaelder S.M., Kulkarni S., Salem H.H., et al. Distinct substrate specificities and functional roles for the 78- and 76-kDa forms of mu-calpain in human platelets. J Biol Chem 272 (1997) 24876-24884
51. Sharma A.K., and Rohrer B. Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 279 (2004) 35564-35572
52. Shiraishi K., Naito K., and Yoshida K. Inhibition of calpain but not caspase protects the testis against injury after experimental testicular torsion of rat. Biol Reprod 63 (2000) 1538-1548
53. Shirasaki Y., Miyashita H., and Yamaguchi M. Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety. Bioorg Med Chem 14 (2006) 5691-5698
54. Shirasaki Y., Miyashita H., Yamaguchi M., et al. Exploration of orally available calpain inhibitors: peptidyl alpha-ketoamides containing an amphiphile at P3 site. Bioorg Med Chem 13 (2005) 4473-4484
55. Sorimachi H., and Suzuki K. The structure of calpain. J Biochem (Tokyo) 129 (2001) 653-664
56. Suzuki K., Hata S., Kawabata Y., et al. Structure, activation, and biology of calpain. Diabetes 53 Suppl (2004) 12-18
57. 2+-independent form of kinase c in long term potentiation. Biochem Biophys Res Comm 189 (1992) 1515-1520
58. Tamada Y., Fukiage C., Daibo S., et al. Involvement of calpain in hypoxia-induced damage in rat retina in vitro. Comp Biochem Physiol B Biochem Mol Biol 131 (2002) 221-225
59. Tamada Y., Nakajima E., Nakajima T., et al. Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia. Brain Res 1050 (2005) 148-155
60. Tsung P.K., and Lombardini J.B. Identification of low-Ca2+- and high-Ca2+-requiring neutral proteases in rat retina. Exp Eye Res 41 (1985) 97-103
61. Ueda Y., Fukiage C., Shih M., et al. Mass measurements of C-terminally truncated alpha-crystallins from two-dimensional gels identify Lp82 as a major endopeptidase in rat lens. Mol Cell Proteomics 1 (2002) 357-365
62. Yokota M., Tani E., Tsubuki S., et al. Calpain inhibitor entrapped in liposome rescues ischemic neuronal damage. Brain Res 819 (1999) 8-14
63. Yoshimura N., Tsukahara I., and Murachi T. Calpain and calpastatin in porcine retina. Identification and action on microtubule-associated proteins. Biochem J 223 (1984) 47-51
64. Zalewska T., Zablocka B., Saido T.C., et al. Dual response of calpain to rat brain postdecapitative ischemia. Mol Chem Neuropathol 33 (1998) 185-197